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Introduction
The number of patients who require removal of
intracardiac leads is increasing. This is not simply
because the number of patients implanted with
cardiovascular implantable electronic devices
(CIEDs), such as pacemakers, implantable cardi-
overter deﬁbrillators (ICDs), or cardiac resynchro-
nization therapy devices (CRT, CRT-D), has in-
creased dramatically, but because the incidence
of complications associated with CIEDs has also
increased. More sick patients with a variety of
morbidities are now indicated for CIED implanta-
tions.
Complete removal of the entire CIED system is
often required in the patients with complications
related to the implanted device, and open-chest and
open-heart removal has been the only approach for
this purpose. This approach can be invasive for the
severely compromised patients. More importantly,
even with the open-heart approach, dissection of the
leads from the veins is not so easy and occasionally
requires systemic deep hypothermia with circulatory
arrest to open the veins for the dissection and
removal of the leads.
Recently, various tools and techniques have
emerged for the transvenous removal of CIED leads.
This manuscript describes the indications, tech-
niques and tools for transvenous lead removal.
Indications for lead extractions
A lead extraction is deﬁned as a lead removal
procedure requiring more complex procedures than
simple traction. The indications for lead extractions
are categorized into infection, chronic pain, throm-
bosis or venous stenosis, functional leads, and
nonfunctional leads. The indication in each cate-
gory has been discussed determined on the basis
of the evidence, and published as an Expert
Consensus.1)
Infection is the major indication for CIED removal
and the complete removal of the entire system is
required for the elimination of the infection. The
CIED infection can present with local signs of
infection, such as pocket pain, an abscess, or skin
erosion (Figure 1), and with critical systemic con-
ditions, such as bacteremia, sepsis, intracardiac or
intravenous vegetation, pulmonary emboli, and
others. Conservative treatments, including antibiot-
ics and debridement, are usually not eﬀective in
most situations. In the patients with an occult
infection, which is deﬁned as continuous positive
cultures without any clinical evidence of an infec-
tion, a lead extraction is strongly recommended.2)
Many patients require a CIED re-implantation
for bradycardia, ventricular tachyarrhythmias, or
heart failure. The question then is raised as to when
we can re-implant a new CIED safely in the patients
who have undergone a removal of an infected device
and the leads. Although there has been little data to
provide a ﬁrm consensus, a relatively early (3 days
later) transvenous re-implantation can be safely
performed in the patients without any evidence of
a systemic infection. In the patients who need an
earlier re-implantation, an epicardial lead implanta-
tion or wearable deﬁbrillator is considered.
Lead extraction in patients without any signs of
infection or other complications is controversial.
Since it is rare for a patient with a failed or no longer
required lead to exhibit any symptoms or to be at risk
of death, it is crucial to balance the risk of the lead
extraction with the risk of leaving the lead implant-
ed. In the patients with severe chronic pain related to
the CIED and not manageable by other therapies, the
lead extraction may be indicated.
In patients with symptoms related to a venous
thrombosis or stenosis, or with restrictions for the
application of the CIEDs or other therapies caused
by a venous occlusion, a lead extraction is recom-
mended. It is not recommended to place a stent in
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the stenotic vein, because the lead will be clamped
against the vein wall, making the future lead
extraction diﬃcult and dangerous.
There are several conditions of functional and
non functional leads recommended for extraction.
The conditions include life threatening arrhythmias
associated with the implanted leads, leads with
potential risk of fracture and following cardiovascu-
lar damage, interference with the normal detection of
arrhythmias by the CIEDs, or restriction restrictions
indicated for other therapies or examinations, such as
radiation, surgery, and magnetic resonance imaging
scanning. Lead removal is reasonable in the patients
already with multiple leads and an implantation of a
CIED will result in more than 4 leads on one side or
more than 5 leads through the SVC.
Various techniques and tools for lead removal
Simple traction using standard stylets and ﬁxation
screw retraction clips may be eﬀective in removing
leads with shorter periods of implantation. Spe-
cialized traction devices, such as locking stylet,
snares, sutures, grasping devices or other types are
eﬀective in engaging or entrapping the leads. The
locking stylets are designed to hold onto the inside
of the lead along its length and are eﬀective in
delivering the traction force to the entire length of
the lead and preventing elongation of the lead body
by the traction.
Various types of sheaths have been developed to
dissect the adhesion between the lead and inside wall
of the vein. Mechanical sheaths are made of metal,
Teﬂon, polypropylene or other materials, and are
used to disrupt the ﬁbrotic attachments around the
lead by the manual advancement of the sheath over
the lead.
A laser sheath delivers a ring of ultraviolet light at
a wavelength of 308 nm generated by an excimer
laser system and vaporizes the scar tissue around the
circumference of the lead to free the leads from the
veins. The laser energy delivery is conﬁned to 50
microns in depth to decrease the risk of penetration.
The success rate of the lead extraction has been
reported to be as high as 94% with a short extraction
time of about 4min.
Electrosurgical dissection sheaths use radiofre-
quency energy emitted between bipolar tungsten
electrodes at the sheath tip to locally dissect the
binding tissue that surrounds and anchors trans-
venous leads. A rotating threaded tip sheath has a
threaded barrel at its distal tip and the ergonomic
trigger handle drives sheath rotation and tip advance-
ment to bore through and disrupt ﬁbrotic attachments
without any electrical energy supplied.3)
A telescoping sheaths technique uses two sheaths
to take advantage of the ﬂexibility of the inner
sheath, such as a laser or rotating threaded tip, and
the stiﬀness of the outer sheath, usually mechanical,
to prevent kinking and to improve the eﬀectiveness
of the advancement over the lead without over-
stressing the lead.
Training and risk management
Because the lead removal is a procedure for
complications of CIEDs, it is diﬃcult to standardize
the procedure. Every patient has a diﬀerent indica-
Figure 1 Infected device and skin erosion
The patient presented with bacteremia and a
skin erosion around the implanted CRTD. The
blood culture was positive for Staphylococcus
aureus and a vegetation was exhibited in the
right atrium. The complete removal of the
generator and intravenous leads was indicated.
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tion for lead extraction. The preoperative evaluation
is extremely important and the therapeutic strategy
should be planned individually (Figure 2). Further,
the procedure has a certain risk of cardiovascular
injury and other additional complications, potentially
leading to mortality. For these reasons, training and
the risk management of the operators and team are
crucial.
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Figure 2 Thin slice CT scan image
The patient had both a pacing lead and ICD lead
inserted from each the right and left subclavian
veins, resulting in a total of 4 leads in the SVC.
The location of each lead in the veins as well as
the extent and degree of the adhesion to the vein
wall should be examined preoperatively.
Asc Ao: ascending aorta, SVC: superior vena
cava
J Arrhythmia Vol 27 No 4 2011
352
